IP Library › Granted Patent US 11,783,941
Granted Patent B2
US 11,783,941 · App. 17/523,527 · Granted Oct 10, 2023

Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof

Inventors: Gary Alan Hayter (Oakland, CA); Andrew H. Naegeli (Walnut Creek, CA)
Assignee: ABBOTT DIABETES CARE INC.
G16H40/63G06K7/10009G16B50/00G16B50/30G16H40/67
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,783,941
App. No.
17/523,527
Granted
Oct 10, 2023
Kind
B2
Abstract

Methods, devices, and kits are provided for determining a compatibility of one or more devices in an analyte monitoring system.

Claims (53)

1. A system comprising:

an integrated sensor and sensor electronics assembly comprising a glucose sensor, wherein the glucose sensor comprises a portion configured to be transcutaneously positioned in the body of a user and to sense glucose levels of the user; and

a drug delivery device comprising a wireless transmitter configured to transmit data related to a configuration of the drug delivery device;

a reader device comprising:

a wireless receiver adapted to receive:

data related to a configuration of the integrated sensor and sensor electronics assembly;

data indicative of an analyte level of a user from the integrated sensor and sensor electronics assembly; and

data related to the configuration of the drug delivery device;

one or more processors; and

non-transitory memory comprising one or more software functions stored thereon that, when executed by the one or more processors, causes the one or more processors to:

determine whether the drug delivery device is compatible with the reader device based at least on the data related to the configuration of the drug delivery device;

determine whether the integrated sensor and sensor electronics assembly is compatible with the reader device based at least on the data related to the configuration of the integrated sensor and sensor electronics assembly;

in response to a determination that the integrated sensor and sensor electronics assembly is compatible, process the data indicative of the analyte level of the user received from the integrated sensor and sensor electronics assembly, and

display the processed data indicative of the analyte level of the user.

2. The system of claim 1 , wherein the data related to the configuration of the integrated sensor and sensor electronics assembly comprises an identification code.

3. The system of claim 1 , wherein the data related to the configuration of the integrated sensor and sensor electronics assembly comprises a key code.

4. The system of claim 1 , wherein the one or more software functions further cause the one or more processors to, in response to a determination that the integrated sensor and sensor electronics assembly is not compatible, communicate a first alarm to the user.

5. The system of claim 4 , wherein the first alarm comprises at least one of an audio alarm, a vibratory alarm, and a visual alarm.

6. The system of claim 1 , wherein the one or more software functions further cause the one or more processors to, in response to a determination that the drug delivery device is not compatible, communicate a second alarm to the user.

7. The system of claim 6 , wherein the second alarm comprises at least one of an audio alarm, a vibratory alarm, and a visual alarm.

8. The system of claim 1 , wherein the drug delivery device further comprises a second wireless transceiver configured to receive data indicative of the analyte level of the user from the integrated sensor and sensor electronics assembly.

9. The system of claim 1 , wherein the drug delivery device is an insulin pump.

10. The system of claim 1 , wherein the one or more software functions further cause the one or more processors to:

determine whether the integrated sensor and sensor electronics assembly is compatible with the reader device by comparing a sensor version of the integrated sensor and sensor electronics assembly with a predetermined list, and

select a software function of the one or more software functions based on the sensor version of the integrated sensor and sensor electronics assembly.

11. The system of claim 1 , wherein the drug delivery device further comprises:

a second wireless receiver configured to receive data indicative of the analyte level of the user;

a second one or more processors;

a second non-transitory memory comprising one or more software functions stored thereon that, when executed by the second one or more processors, causes the second one or more processors to:

display processed data indicative of the analyte level of the user.

12. A system comprising:

an integrated sensor and sensor electronics assembly comprising a glucose sensor, wherein the glucose sensor comprises a portion configured to be transcutaneously positioned in the body of a user and to sense glucose levels of the user;

a reader device comprising:

a first wireless receiver adapted to receive:

data related to a configuration of the integrated sensor and sensor electronics assembly, wherein the data related to the configuration comprises an identification code associated with the integrated sensor and sensor electronics assembly;

data indicative of an analyte level of a user from the integrated sensor and sensor electronics assembly; and

one or more processors; and

non-transitory memory comprising one or more software functions stored thereon that, when executed by the one or more processors, causes the one or more processors to:

determine, based at least in part on the identification code, whether the integrated sensor and sensor electronics assembly is compatible with the reader device;

process the data indicative of the analyte level of the user received from the integrated sensor and sensor electronics assembly using a software function correlated with the configuration of the integrated sensor and sensor electronics assembly; and

display the processed data indicative of the analyte level of the user;

a drug delivery device comprising a second wireless receiver adapted to receive the data indicative of the analyte level of the user.

13. The system of claim 12 , wherein the drug delivery device further comprises:

a second one or more processors;

a second non-transitory memory comprising second one or more software functions stored thereon that, when executed by the second one or more processors, causes the second one or more processors to:

display processed data indicative of the analyte level of the user.

14. The system of claim 13 , wherein the second one or more software functions further cause the second one or more processors to process the data indicative of the analyte level of the user.

15. The system of claim 14 , wherein the second wireless receiver is adapted to receive the software function correlated with the configuration of the integrated sensor and sensor electronics assembly from the reader device.

16. The system of claim 15 , wherein the second one or more software functions further cause the second one or more processors to process the data indicative of the analyte level of the user using the software function correlated with the configuration of the integrated sensor and sensor electronics assembly from the reader device.

17. The system of claim 12 , wherein the drug delivery device is an insulin pump.

18. The system of claim 12 , wherein the software function is retrieved from a server.

19. The system of claim 12 , wherein the software function is retrieved from one or more components of the reader device.

20. The system of claim 12 , wherein the first wireless receiver is adapted to receive the data indicative of the analyte level of the user from the integrated sensor and sensor electronics assembly via BLUETOOTH protocol.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2021
From: HAYTER, GARY ALAN; NAEGELI, ANDREW H.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 058106/0239 →
Continuity (5)
Continuation 15640058 · Jun 30, 2017
Continuation 15065604 · Mar 9, 2016
Continuation 13684085 · Nov 21, 2012
Provisional Application 61563517 · Nov 23, 2011
Related Publication 20220181013A1 · Jun 9, 2022
Cited By (1)
US 12,254,978